MarketsLiveIdeasAPI
Trending
New
路
Trending
New
AllPoliticsSportsCultureCryptoClimateEconomicsMentionsCompaniesFinancialsTech & Science
All
Football
Basketball
Hockey
Soccer
Tennis
ATP Challenger Itajai
ATP Challenger Oeiras 1
ATP Challenger Oeiras 2
ATP Challenger Phan Thiet
ATP Challenger Phan Thiet 2
ATP Challenger Soma Bay
Australian Open
Australian Open Men Singles
Australian Open Women Singles

Golf
MMA
Cricket
Baseball
Boxing
Chess
Esports
Motorsport
Olympics

ATP Challenger Phan Thiet 2

ATP Challenger Phan Thiet 2
馃寪
Chase Ferguson
6
2
15
馃寪
Arthur Weber7
4
3
0
--%
--%
LIVE
ATP Challenger Phan Thiet 2
馃寪
Lorenzo Carboni6
6
2
30
馃寪
Kokoro Isomura
3
1
30
--%
--%
LIVE
ATP Challenger Phan Thiet 2
馃寪
David Jorda Sanchis3
6
2
40
馃寪
Thanh Minh Truong
1
2
30
--%
--%
LIVE
ATP Challenger Phan Thiet 2
馃寪
Justin Barki
馃寪
Hiroki Moriya11
--%
--%
Jan 25 @ 12:50am EST
ATP Challenger Phan Thiet 2
馃寪
Marek Gengel
馃寪
Ji Sung Nam
--%
--%
Jan 25 @ 1:00am EST
ATP Challenger Phan Thiet 2
馃寪
Michele Ribecai
馃寪
Joshua Charlton
--%
--%
Jan 25 @ 1:00am EST
ATP Challenger Phan Thiet 2
馃寪
Ethan Cook
馃寪
Vladyslav Orlov
--%
--%
Jan 25 @ 2:10am EST
ATP Challenger Phan Thiet 2
馃寪
Minh Phat Nguyen
馃寪
Moerani Bouzige
--%
--%
Jan 25 @ 2:10am EST
Company
BlogCareersPrivacy PolicyData Terms of ServiceCompanyBrand Kit
Social
X (Twitter)LinkedInDiscordInstagramRedditTikTok
Product
Help CenterAPIFAQFAQ for Finance ProfessionalsRegulatoryTrading HoursFee ScheduleTrading ProhibitionsIncentive ProgramResearch

漏 2026 Kalshi Inc.
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.